A phase I/2a dose-escalation trial of intravenous CG7870 in combination with docetaxel in chemotherapy-naive patients with metastatic hormone-refractory prostate cancer
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2006
At a glance
- Drugs CG 7870 (Primary) ; Docetaxel
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Oct 2005 New trial record.